封面
市场调查报告书
商品编码
1746735

日本体外膜氧合机市场报告(按组件、模式、应用和地区)2025-2033

Japan Extracorporeal Membrane Oxygenation Machine Market Report by Component, Modality, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年,日本体外膜氧合机 (ECMO) 市场规模达3,310万美元。展望未来, IMARC Group预计到2033年,该市场规模将达到5,010万美元,2025-2033年期间的复合年增长率 (CAGR) 为4.7%。持续的研发投入推动了更先进的ECMO设备的发展,这些设备功能和性能均有所提升,包括更小巧、更便携的设备以及更好的生物相容性,这些都推动着市场的发展。

体外膜氧合机 (ECMO) 是一种用于为严重呼吸衰竭或心臟衰竭患者提供临时支援的救命医疗设备。它充当体外人工肺和/或人工心臟,从患者体内抽取血液,进行氧合,去除二氧化碳,然后将其输回体内,使患者自身的器官得到休息和修復。 ECMO 由多个部件组成,包括帮浦、氧合器和导管。帮浦维持血流,氧合器补充氧气并去除二氧化碳。 ECMO 可用于多种疾病,例如急性呼吸窘迫症候群 (ARDS)、心臟衰竭或复杂的心臟手术。它通常是常规治疗失败后的最后手段,为復健或移植提供过渡。 ECMO 需要专业的医疗团队进行管理和监控。

日本体外膜氧合机(ECMO)市场趋势:

近年来,日本体外膜氧合机 (ECMO) 市场经历了显着成长,这得益于几个关键驱动因素。首先,呼吸系统疾病(例如急性呼吸窘迫症候群 (ARDS) 和心因性休克)的盛行率不断上升,显着增加了对 ECMO 的需求。此外,日本人口老化导致慢性病发病率上升,进一步推动了 ECMO 市场的发展。此外,ECMO 技术的进步,包括更紧凑、更易于使用的设备的开发,使得 ECMO 治疗在更广泛的医疗环境中更容易获得和可行。这些创新有助于扩大市场覆盖范围。此外,ECMO 作为重症患者救命干预措施的重要性日益增加,这导致需求激增,并推动了对 ECMO 基础设施的大量投资。总而言之,疾病盛行率的上升、技术进步以及人们对 ECMO 在重症监护场景中有效性的认识不断提高,这些因素共同推动了预测期内日本 ECMO 市场的发展。

日本体外膜氧合机(ECMO)市场细分:

组件洞察:

  • 氧合器
  • 套管
  • 配件
  • 控制器
  • 泵浦

模态洞察:

  • 静脉动脉ECMO
  • 静脉ECMO
  • 动静脉ECMO

应用程式洞察:

  • 心臟应用
  • 呼吸应用
  • 体外心肺復苏

竞争格局:

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。

本报告回答的关键问题:

  • 日本体外膜氧合机(ECMO)市场迄今表现如何,未来几年将如何表现?
  • COVID-19 对日本体外膜氧合机 (ECMO) 市场有何影响?
  • 日本体外膜氧合机(ECMO)市场依组件分類的分布如何?
  • 日本体外膜氧合机(ECMO)市场依模式分類的分布如何?
  • 日本体外膜氧合机(ECMO)市场根据应用如何分布?
  • 日本体外膜氧合机(ECMO)市场的价值链分为哪些阶段?
  • 日本体外膜氧合机(ECMO)的关键驱动因素和挑战是什么?
  • 日本体外膜氧合机(ECMO)市场的结构是怎么样的?主要参与者有哪些?
  • 日本体外膜氧合机(ECMO)市场的竞争程度如何?

本报告回答的关键问题:

  • 日本体外膜氧合机(ECMO)市场迄今表现如何,未来几年将如何表现?
  • COVID-19 对日本体外膜氧合机 (ECMO) 市场有何影响?
  • 日本体外膜氧合机(ECMO)市场依组件分類的分布如何?
  • 日本体外膜氧合机(ECMO)市场依模式分類的分布如何?
  • 日本体外膜氧合机(ECMO)市场根据应用如何分布?
  • 日本体外膜氧合机(ECMO)市场的价值链分为哪些阶段?
  • 日本体外膜氧合机(ECMO)的关键驱动因素和挑战是什么?
  • 日本体外膜氧合机(ECMO)市场的结构是怎么样的?主要参与者有哪些?
  • 日本体外膜氧合机(ECMO)市场的竞争程度如何?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:日本体外膜氧合机(ECMO)市场-简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章:日本体外膜氧合机(ECMO)市场格局

  • 历史与当前市场趋势(2019-2024)
  • 市场预测(2025-2033)

第六章:日本体外膜氧合机(ECMO)市场-细分:依组件

  • 氧合器
    • 概述
  • 套管
    • 概述
  • 配件
    • 概述
  • 控制器
    • 概述
  • 泵浦
    • 概述

第七章:日本体外膜氧合机(ECMO)市场-细分:依设备类型

  • 静脉动脉ECMO
    • 概述
  • 静脉ECMO
    • 概述
  • 动静脉ECMO
    • 概述

第 8 章:日本体外膜氧合机 (ECMO) 市场 - 细分:按应用

  • 心臟应用
    • 概述
  • 呼吸应用
    • 概述
  • 体外心肺復苏
    • 概述

第九章:日本体外膜氧合机(ECMO)市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十章:关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本体外膜氧合机 (ECMO) 市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章:附录

简介目录
Product Code: SR112025A20818

Japan extracorporeal membrane oxygenation machine (ECMO) market size reached USD 33.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 50.1 Million by 2033, exhibiting a growth rate (CAGR) of 4.7% during 2025-2033. The ongoing R&D efforts, which have led to the development of more advanced ECMO machines with improved features and capabilities, including smaller, more portable devices and better biocompatibility, is driving the market.

An extracorporeal membrane oxygenation machine (ECMO) is a life-saving medical device used to provide temporary support to patients with severe respiratory or cardiac failure. It functions as an external artificial lung and/or heart by drawing blood from the patient, oxygenating it, removing carbon dioxide, and then returning it to the body, allowing the patient's own organs to rest and heal. ECMO consists of several components, including a pump, oxygenator, and tubing. The pump maintains blood flow while the oxygenator adds oxygen and removes carbon dioxide. ECMO can be used for various conditions, such as acute respiratory distress syndrome (ARDS), heart failure, or during complex cardiac surgeries. It is typically employed as a last resort when conventional treatments fail and provides a bridge to recovery or transplantation. ECMO requires a specialized team of healthcare professionals for its management and monitoring.

Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market Trends:

The extracorporeal membrane oxygenation machine (ECMO) market in Japan has witnessed remarkable growth in recent years, owing to several key drivers. Firstly, the increasing prevalence of respiratory and cardiac disorders, such as ARDS and cardiogenic shock, has significantly boosted the demand for ECMO machines. Additionally, the aging population in Japan has led to a higher incidence of chronic diseases, further propelling the ECMO market forward. Furthermore, advancements in ECMO technology, including the development of more compact and user-friendly devices, have made ECMO therapy more accessible and feasible for a broader range of healthcare settings. These innovations have been instrumental in expanding the market's reach. Moreover, the growing importance of ECMO as a life-saving intervention for critically ill patients is creating a surge in demand and driving substantial investments in ECMO infrastructure. In conclusion, a combination of increasing disease prevalence, technological advancements, and the heightened awareness of ECMO's effectiveness in critical care scenarios has been instrumental in steering the ECMO market in Japan during the forecast period.

Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market Segmentation:

Component Insights:

  • Oxygenators
  • Cannula
  • Accessories
  • Controllers
  • Pumps

Modality Insights:

  • Venoarterial ECMO
  • Venovenous ECMO
  • Arteriovenous ECMO

Application Insights:

  • Cardiac Applications
  • Respiratory Applications
  • Extracorporeal Cardiopulmonary Resuscitation

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan extracorporeal membrane oxygenation machine (ECMO) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan extracorporeal membrane oxygenation machine (ECMO) market?
  • What is the breakup of the Japan extracorporeal membrane oxygenation machine (ECMO) market on the basis of component?
  • What is the breakup of the Japan extracorporeal membrane oxygenation machine (ECMO) market on the basis of modality?
  • What is the breakup of the Japan extracorporeal membrane oxygenation machine (ECMO) market on the basis of application?
  • What are the various stages in the value chain of the Japan extracorporeal membrane oxygenation machine (ECMO) market?
  • What are the key driving factors and challenges in the Japan extracorporeal membrane oxygenation machine (ECMO)?
  • What is the structure of the Japan extracorporeal membrane oxygenation machine (ECMO) market and who are the key players?
  • What is the degree of competition in the Japan extracorporeal membrane oxygenation machine (ECMO) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Breakup by Component

  • 6.1 Oxygenators
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Cannula
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Accessories
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Controllers
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Pumps
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)

7 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Breakup by Modality

  • 7.1 Venoarterial ECMO
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Venovenous ECMO
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Arteriovenous ECMO
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Breakup by Application

  • 8.1 Cardiac Applications
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Respiratory Applications
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Extracorporeal Cardiopulmonary Resuscitation
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)

9 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market -Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix